Article

GE Healthcare is significantly ramping up its research and development efforts, particularly in artificial intelligence and digital solutions, to enhance healthcare productivity and outcomes. Despite experiencing a downturn in the Chinese market due to recent anti-corruption measures, the company anticipates moderate growth in the region.

Strategic mergers and acquisitions are prioritized to improve product offerings, with new launches in cardiac imaging and PET expected to drive further growth. The integration of AI across its products aims to tackle challenges like labor shortages while enhancing operational efficiencies.